Legend Biotech Corp

LEGN chart

Legend Biotech Corp news

• Legend Biotech Corp (LEGN) Q3 2026 Earnings Call Highlights: CARVYKTI Sales Jump 36% as ...

  Yahoo Finance · Nov 10, 4:05 PM EST

• LEGN Stock On Track For Worst Day Ever As Investors Focus On Decelerating US Demand For CARVYKTI Therapy

  stocktwits.com · Nov 10, 3:11 PM EST

• What Legend Biotech (LEGN) Said on Its Q3 Earnings Call

  marketbeat.com · Nov 10, 12:15 PM EST

• Legend Biotech Reports Third Quarter 2026 Results and Recent Highlights

  Yahoo Finance · Nov 10, 7:00 AM EST

• Gabelli Releases Agenda for 8th Annual Healthcare Symposium

  Yahoo Finance · Nov 9, 8:00 AM EST

• Legend Biotech to Showcase CARVYKTI® Leadership and Next-Generation Cell Therapy Innovation at ASH 2026

  Yahoo Finance · Nov 4, 9:00 AM EST

• A $2 Billion Fund Bought These 3 Stocks Last Quarter

  tikr.com · Nov 2, 5:40 AM EST

• Legend Biotech Corporation Sponsored ADR (LEGN) Recently Broke Out Above the 200-Day Moving Average

  Yahoo Finance · Oct 29, 8:30 AM EDT

• Legend Biotech (LEGN) Stock Could Trade Below Its Sales Backdrop

  Yahoo Finance · Oct 28, 2:20 AM EDT

• Legend Biotech Corporation Sponsored ADR (LEGN) Crossed Above the 50-Day Moving Average: What That Means for Investors

  Yahoo Finance · Oct 27, 8:30 AM EDT

• Legend Biotech to Host Investor Conference Call on Third Quarter 2026 Results

  Yahoo Finance · Oct 27, 8:00 AM EDT

• Morgan Stanley turns bearish on Vonovia, LEG as Berlin housing risks mount

  Yahoo Finance · Oct 20, 6:28 AM EDT

Legend Biotech Corp key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-11-10
• 6-KFORM 6-K2026-11-04
• 6-KFORM 6-K2026-10-15
• 6-KFORM 6-K2026-10-13
• 6-KFORM 6-K2026-09-25
• 6-KFORM 6-K2026-09-24
• 6-KFORM 6-K2026-09-15
• 6-KFORM 6-K2026-09-14
• 6-KFORM 6-K2026-08-18
• 6-K6-K2026-08-11
• 6-KFORM 6-K2026-08-06
• 6-K6-K2026-07-27

About Legend Biotech Corp

Ticker

LEGN (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Somerset, NJ

Incorporated in

Cayman Islands

Fiscal year end

December 31

SEC CIK

1801198

Frequently asked questions